發(fā)布時(shí)間：2018-04-28 14:58

  本文選題：阿爾茨海默病 + 基質(zhì)金屬蛋白酶�。� 參考：《鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版)》2014年01期

【摘要】：正阿爾茨海默病(Alzheimer's disease,AD)是老年期常見的中樞神經(jīng)系統(tǒng)疾病,是癡呆的主要類型。國(guó)外最新的AD診斷標(biāo)準(zhǔn)的推薦指南中已納入了如腦脊液中β-淀粉樣蛋白(Aβ)、Tau蛋白等生物標(biāo)志物[1],說明生物標(biāo)志物在AD診斷中的作用日益受到重視,然而具有較高敏感度及特異度的血漿診斷標(biāo)志物目前尚未找到[2]�；|(zhì)金屬蛋白酶(matrix
[Abstract]:Alzheimer's disease (AD) is a common central nervous system disease in the elderly and is the main type of dementia. Biomarkers such as 尾 -amyloid A 尾 -butenau protein in cerebrospinal fluid (CSF) have been included in the recommended guidelines for the latest diagnostic criteria for AD in foreign countries, indicating that the role of biomarkers in the diagnosis of AD has been paid more and more attention. However, plasma diagnostic markers with high sensitivity and specificity have not been found [2]. Matrix metalloproteinase matrix
【作者單位】： 鄭州大學(xué)第一附屬醫(yī)院神經(jīng)內(nèi)科;
【分類號(hào)】：R749.16

【參考文獻(xiàn)】

相關(guān)期刊論文 前5條

1 蔣平;陳鳴;呂軍;陳，

本文編號(hào)：1815750